HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joanne Lysaght Selected Research

Joanne Lysaght Research Topics

Disease

40Neoplasms (Cancer)
07/2022 - 06/2003
18Adenocarcinoma
06/2022 - 02/2012
11Obesity
01/2022 - 08/2011
5Inflammation (Inflammations)
01/2020 - 01/2016
4Carcinogenesis
03/2021 - 12/2007
4Neuralgia (Stump Neuralgia)
01/2021 - 01/2020
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
07/2022 - 06/2020
3Neoplasm Metastasis (Metastasis)
06/2022 - 09/2007
3Pain (Aches)
01/2021 - 01/2018
2Hypoxia (Hypoxemia)
05/2022 - 12/2020
2Esophageal Squamous Cell Carcinoma
06/2020 - 02/2012
2Lung Neoplasms (Lung Cancer)
01/2020 - 01/2016
2Disease Progression
04/2019 - 01/2016
2Barrett Esophagus (Barrett's Esophagus)
01/2019 - 02/2012
2Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2013 - 08/2011
1Carcinoma (Carcinomatosis)
07/2022
1Neoplasm Micrometastasis
07/2022
1Acidosis
06/2022
1Melanoma (Melanoma, Malignant)
01/2021
1Bites and Stings (Sting)
01/2021
1Ulcerative Colitis
12/2020
1Colonic Neoplasms (Colon Cancer)
06/2020
1Rectal Neoplasms (Rectal Cancer)
06/2020
1Stomach Neoplasms (Stomach Cancer)
06/2020
1Neuroinflammatory Diseases
01/2020
1Fibromyalgia (Fibrositis)
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016
1Mitochondrial Diseases (Mitochondrial Disease)
12/2014
1Necrosis
03/2014
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2014
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2013

Drug/Important Bio-Agent (IBA)

7ChemokinesIBA
09/2021 - 01/2016
5Immune Checkpoint InhibitorsIBA
06/2022 - 01/2020
5CytokinesIBA
01/2021 - 07/2006
3Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2003
3EnzymesIBA
12/2014 - 12/2007
3Messenger RNA (mRNA)IBA
02/2012 - 07/2006
2Interleukin-10 (Interleukin 10)IBA
06/2022 - 07/2006
2AntigensIBA
01/2022 - 09/2003
2Biological ProductsIBA
09/2021 - 01/2021
2Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2018
2GoldIBA
08/2021 - 10/2019
2Chemokine CX3CL1IBA
01/2021 - 01/2018
2Conditioned Culture MediaIBA
01/2021 - 01/2019
2Amitriptyline (Elavil)FDA LinkGeneric
01/2021 - 01/2020
2NeuropeptidesIBA
01/2021 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
12/2020 - 06/2003
2Peptides (Polypeptides)IBA
01/2020 - 06/2003
2Interleukin-8 (Interleukin 8)IBA
01/2019 - 03/2014
2Chemokine ReceptorsIBA
12/2016 - 01/2016
2RNA (Ribonucleic Acid)IBA
01/2016 - 06/2003
2AdipokinesIBA
03/2014 - 08/2011
2LeptinIBA
03/2014 - 08/2011
1Lactic Acid (Lactate)FDA LinkGeneric
06/2022
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
06/2022
1Glucose (Dextrose)FDA LinkGeneric
05/2022
1C-Reactive ProteinIBA
03/2022
1Immune Checkpoint ProteinsIBA
06/2021
1Complement System Proteins (Complement)IBA
03/2021
1Dihydrotachysterol (AT 10)IBA
01/2021
1Opioid Receptors (Opioid Receptor)IBA
01/2021
1Opioid Analgesics (Opioids)IBA
01/2021
1CX3C Chemokine Receptor 1IBA
01/2021
1ProteomeIBA
01/2021
1SmokeIBA
12/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020
1Interleukin-12 (IL 12)IBA
11/2020
1Blood Proteins (Serum Proteins)IBA
11/2020
1HLA-DR Antigens (HLA-DR)IBA
06/2020
1salicylhydroxamic acid (SHAM)IBA
01/2020
1ferric oxide (iron oxide)IBA
10/2019
1Liposomes (Liposome)IBA
10/2019
1Silicon Dioxide (Silica)FDA LinkGeneric
10/2019
1Dendrimers (Dendrons)IBA
10/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2018
1Galactosylceramides (Galactocerebrosides)IBA
01/2018
1Interleukin-17 (Interleukin 17)IBA
01/2018
1GlycolipidsIBA
01/2018
1baicaleinIBA
01/2016
1Adenosine Triphosphate (ATP)IBA
12/2014
1InterleukinsIBA
03/2014
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
03/2014
1Indicators and Reagents (Reagents)IBA
03/2013
1Matrix Metalloproteinases (MMPs)IBA
02/2013
1IntegrinsIBA
01/2013
14- acetoxy- 5- (1- (naphthyl))naphtho(2,3- b)pyrrolo(2,1- d)(1,4)oxazepineIBA
01/2013

Therapy/Procedure

15Therapeutics
07/2022 - 06/2003
13Immunotherapy
07/2022 - 01/2014
9Drug Therapy (Chemotherapy)
07/2022 - 01/2020
4Radiotherapy
07/2022 - 01/2020
3Neoadjuvant Therapy
06/2020 - 01/2018
2Combined Modality Therapy
04/2022 - 01/2022
2Aftercare (After-Treatment)
01/2021 - 06/2020
2Pulsed Radiofrequency Treatment
01/2020 - 01/2018
1Perioperative Period
07/2022
1Chemoradiotherapy
06/2022
1Immunomodulation
06/2022
1Spinal Cord Stimulation
01/2020
1Quantum Dots (Quantum Dot)
10/2019
1Medical Day Care (Partial Hospitalization)
01/2018